, Tracking Stock Market Picks
Enter Symbol:
Genomic Health, Inc. (GHDX) [hlAlert]

up 16.31 %

Genomic Health, Inc. (GHDX) rated Underperform by Raymond James

Posted on: Monday,  Sep 23, 2013  8:25 AM ET by Raymond James

Raymond James rated Underperform Genomic Health, Inc. (NASDAQ: GHDX) on 09/23/2013, when the stock price was $31.09. Since
then, Genomic Health, Inc. has lost 14.02% as of 01/06/2016's recent price of $26.73.
If you would have followed this Raymond James's recommendation on GHDX, you would have gained 16.31% of your investment in 835 days.

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. It launched its first test, Oncotype DX, which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients. The Oncotype DX assay represents the first diagnostic gene expression test on the market that provides consistent results across multiple independent trials having breast cancer patients, including a large validation study of The New England Journal of Medicine.

Our equity research team has gained national attention for stock-picking ability and analyst performance, with recognition in leading publications such as the Wall Street Journal and Institutional Investor magazine*. Raymond James’ equity research philosophy focuses on a fundamental approach that encompasses three basic points. First, we believe that superior research on select companies within well-defined industries is preferable to broad general coverage. Second, we concentrate on the identification of quality companies demonstrating solid growth potential, with the goal of helping our clients maximize their investment returns. Third, to help our clients take advantage of pockets of inefficiency in the market, we strive to locate superior companies from across the country that have the potential to provide our clients with unique opportunities.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/23/2013 8:25 AM Sell
as of 12/13/2013
1 Week up  9.94 %
1 Month up  12.53 %
3 Months up  2.41 %
1 YTD up  2.41 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy